Publications
View and download slide summaries of the latest original articles focusing on cytokine signalling therapies within rheumatoid arthritis. All materials produced by the CSF team are subsequently reviewed and approved by individual Steering Committee members.
March 2023
Seguridad de los Fármacos Modificadores de la Enfermedad Biológicos y Dirigidos Sintéticos en Artritis Reumatoide cómo Utilizados en la Práctica Clínica: Resultados del Programa ARTIS
Ann Rheum Dis. 2023 doi: 10.1136/ard-2022-223762 Epub ahead of print
Nationwide register-based cohort study corroborates and extends previous evidence that the currently available biologic/targeted synthetic DMARDs have an acceptable and, on the whole, similar safety profile.